Financial insights of ORMP

MyFinsight

For the quarter ending 2025-09-30.

Unit: Dollar

Income Statement	2025-09-30	2025-06-30	2024-12-31
Revenues	-	0	-
Cost of revenue	-	0	-
Gross profit	-	0	-
Research and development expenses	1,153,000	1,034,000	1,320,000
General and administrative expenses	1,274,000	1,455,000	1,958,500
Operating loss	-2,427,000	-2,489,000	-3,278,500
Other income, net	408,000	257,000	-
Financial income (loss), net	61,470,000	15,366,000	-550,000
Interest expenses	-	0	197,333.333
Income (loss) before tax expenses	59,451,000	13,134,000	-4,124,500
Tax expenses	11,062,000	-126,000	208,000
Net income (loss)	48,389,000	13,260,000	-
Non-controlling interests	-6,000	-28,000	-
Companys stockholders	48,395,000	13,288,000	-4,348,000

Basic income (loss) per share of common stock (in dollars per share)	1.16	0.32	-0.11
Diluted income (loss) per share of common stock (in dollars per share)	1.13	0.31	-0.11
Weighted average number of shares of common stock used in computing basic income per share of common stock (in shares)	41,756,301	41,743,486	-20,514,112
Weighted average number of shares of common stock used in computing diluted income per share of common stock (in shares)	42,774,504	42,609,425	-20,829,736